AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 6389142 — intervention group
Group type: EXPERIMENTAL
Intervention: Chronic antidysrhythmic treatment (specific agents not mentioned)
Number of subjects: 568
Study 6389142 — intervention group
Group type: COMPARATOR
Intervention: Control (not specified, but implied to be no treatment or placebo)
Number of subjects: 568
Study 6389142 — intervention group
Group type: EXPERIMENTAL
Intervention: Chronic antidysrhythmic treatment
Number of subjects: 568
Study 6389142 — intervention group
Group type: COMPARATOR
Intervention: Control (not specified)
Number of subjects: 568
Study 31481144 — intervention group
Group type: EXPERIMENTAL
Intervention: Holmium laser enucleation of the prostate (HoLEP)
Number of subjects: 80
Study 31481144 — intervention group
Group type: COMPARATOR
Intervention: Transurethral resection of the prostate (TURP)
Number of subjects: 80
Study 29970142 — intervention group
Group type: EXPERIMENTAL
Intervention: Whole-body vibration strength-training for 6 weeks
Number of subjects: 82
Study 29970142 — intervention group
Group type: COMPARATOR
Intervention: Placebo intervention for 6 weeks
Number of subjects: 82
Study 29970142 — intervention group
Group type: EXPERIMENTAL
Intervention: Whole-body vibration strength-training
Number of subjects: 82
Study 26597179 — intervention group
Group type: EXPERIMENTAL
Intervention: Edoxaban 60 mg daily for 3 days
Number of subjects: 0
Study 26597179 — intervention group
Group type: COMPARATOR
Intervention: Switching from Rivaroxaban 20 mg daily to Edoxaban 60 mg
Number of subjects: 0
Study 26597179 — intervention group
Group type: COMPARATOR
Intervention: Switching from Dabigatran Etexilate 150 mg twice daily to Edoxaban 60 mg
Number of subjects: 0
Study 25316860 — intervention group
Group type: EXPERIMENTAL
Intervention: tOPV with sodium bicarbonate and sodium citrate buffer
Number of subjects: 0
Study 25316860 — intervention group
Group type: COMPARATOR
Intervention: tOPV without buffer (control)
Number of subjects: 0
Study 27536427 — intervention group
Group type: EXPERIMENTAL
Intervention: MLK 10mg (7-day administration)
Number of subjects: 106
Study 27536427 — intervention group
Group type: EXPERIMENTAL
Intervention: MLK 10mg (3-day administration)
Number of subjects: 106
Study 27536427 — intervention group
Group type: EXPERIMENTAL
Intervention: MLK 10mg (1-day administration)
Number of subjects: 106
Study 27536427 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 106
Study 19822605 — intervention group
Group type: EXPERIMENTAL
Intervention: Mild hypothermia (32 degrees C)
Number of subjects: 30
Study 19822605 — intervention group
Group type: COMPARATOR
Intervention: Moderate hypothermia (25 degrees C)
Number of subjects: 30
Study 17506738 — intervention group
Group type: EXPERIMENTAL
Intervention: LMA Classic
Number of subjects: 72
Study 17506738 — intervention group
Group type: EXPERIMENTAL
Intervention: Intubating laryngeal mask
Number of subjects: 72
Study 17506738 — intervention group
Group type: EXPERIMENTAL
Intervention: Berman airway
Number of subjects: 72
Study 17506738 — intervention group
Group type: COMPARATOR
Intervention: Senior House Officers
Number of subjects: 72
Study 17506738 — intervention group
Group type: COMPARATOR
Intervention: All grades of anaesthetists
Number of subjects: 72
Study 17599422 — intervention group
Group type: EXPERIMENTAL
Intervention: Therapeutic strategy targeting HbA1c level of <6.0%
Number of subjects: 10251
Study 17599422 — intervention group
Group type: EXPERIMENTAL
Intervention: Fenofibrate
Number of subjects: 10251
Study 17599422 — intervention group
Group type: EXPERIMENTAL
Intervention: Statin plus fenofibrate
Number of subjects: 10251
Study 17599422 — intervention group
Group type: EXPERIMENTAL
Intervention: Therapeutic strategy targeting systolic blood pressure of <120 mm Hg
Number of subjects: 10251
Study 17599422 — intervention group
Group type: COMPARATOR
Intervention: Statin plus placebo
Number of subjects: 10251
Study 17599422 — intervention group
Group type: COMPARATOR
Intervention: Therapeutic strategy targeting systolic blood pressure of <140 mm Hg
Number of subjects: 10251
Study 12925048 — intervention group
Group type: EXPERIMENTAL
Intervention: Hydrochlorothiazide (HCTZ) 12.5 mg od
Number of subjects: 18
Study 12925048 — intervention group
Group type: EXPERIMENTAL
Intervention: Indapamide 2.5 mg od
Number of subjects: 18
Study 10843301 — intervention group
Group type: EXPERIMENTAL
Intervention: Alcohol (dose sufficient to raise blood alcohol level to .08)
Number of subjects: 59
Study 10843301 — intervention group
Group type: EXPERIMENTAL
Intervention: Placebo (believed to have consumed alcohol but had not)
Number of subjects: 59
Study 10843301 — intervention group
Group type: COMPARATOR
Intervention: No alcohol (neither expected nor received alcohol)
Number of subjects: 59
Study 9377894 — intervention group
Group type: EXPERIMENTAL
Intervention: Heated humidifier
Number of subjects: 40
Study 9377894 — intervention group
Group type: COMPARATOR
Intervention: Heat and moisture exchanger
Number of subjects: 40
Study 9377894 — intervention group
Group type: EXPERIMENTAL
Intervention: Passive airway humidification by a heat and moisture exchanger
Number of subjects: 40
Study 8076052 — intervention group
Group type: EXPERIMENTAL
Intervention: Carotid endarterectomy
Number of subjects: 2
Study 8076052 — intervention group
Group type: COMPARATOR
Intervention: Conventional medical therapy
Number of subjects: 2
Study 8076052 — intervention group
Group type: COMPARATOR
Intervention: Conventional non-operative treatment
Number of subjects: 2
Study 3987178 — intervention group
Group type: COMPARATOR
Intervention: Cimetidine (300 mg every 6 hours by mouth)
Number of subjects: 6
Study 3987178 — intervention group
Group type: COMPARATOR
Intervention: Ranitidine (160 mg every 12 hours by mouth)
Number of subjects: 6
Study 3987178 — intervention group
Group type: COMPARATOR
Intervention: Placebo (2 days)
Number of subjects: 6
Study 3987178 — intervention group
Group type: COMPARATOR
Intervention: Untreated state (O)
Number of subjects: 6
Study 31654567 — intervention group
Group type: EXPERIMENTAL
Intervention: Multidomain lifestyle program (psychoeducational material, physical activity tracker, nutrition tracker, audio-based meditations, health coaching)
Number of subjects: 559
Study 29495607 — intervention group
Group type: EXPERIMENTAL
Intervention: Astaxanthin and Sesamin (AS)
Number of subjects: 24
Study 29495607 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 24
Study 27565061 — intervention group
Group type: EXPERIMENTAL
Intervention: Model building group (n=304)
Number of subjects: 604
Study 27565061 — intervention group
Group type: COMPARATOR
Intervention: Test group (n=300)
Number of subjects: 604
Study 24712335 — intervention group
Group type: EXPERIMENTAL
Intervention: Telephonic medication therapy management (MTM) intervention
Number of subjects: 895
Study 24712335 — intervention group
Group type: COMPARATOR
Intervention: Usual care (control)
Number of subjects: 895
Study 23060426 — intervention group
Group type: EXPERIMENTAL
Intervention: Mipomersen 200 mg weekly subcutaneous
Number of subjects: 124
Study 23060426 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 124
Study 20420153 — intervention group
Group type: EXPERIMENTAL
Intervention: AWS with bougie
Number of subjects: 40
Study 20420153 — intervention group
Group type: COMPARATOR
Intervention: AWS only
Number of subjects: 40
Study 19127911 — intervention group
Group type: EXPERIMENTAL
Intervention: General regulation acupuncture and cupping therapy (warming needle moxibustion, plum-blossom needle, moving cupping, retaining the cup), thrice each week for 3 months
Number of subjects: 60
Study 16519385 — intervention group
Group type: EXPERIMENTAL
Intervention: Latex agglutination test
Number of subjects: 287
Study 12808177 — intervention group
Group type: EXPERIMENTAL
Intervention: Daytime dwell with 1100 ml/m2 icodextrin solution for one week (week 2)
Number of subjects: 8
Study 10584283 — intervention group
Group type: EXPERIMENTAL
Intervention: Preseasonal short-term immunotherapy
Number of subjects: 0
Study 10584283 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 8738859 — intervention group
Group type: EXPERIMENTAL
Intervention: Magnesium infusion (8.12 mmol/day, group A, n = 81)
Number of subjects: 355
Study 8738859 — intervention group
Group type: EXPERIMENTAL
Intervention: Potassium infusion (10.49 mmol/day, group B, n = 77)
Number of subjects: 355
Study 8738859 — intervention group
Group type: COMPARATOR
Intervention: 10% dextrose solution (group C, n = 87)
Number of subjects: 355
Study 8738859 — intervention group
Group type: COMPARATOR
Intervention: Placebo (2% dextrose solution, group D, n = 81)
Number of subjects: 355
Study 1808632 — intervention group
Group type: EXPERIMENTAL
Intervention: Cyclopenthiazide 125 micrograms
Number of subjects: 24
Study 1808632 — intervention group
Group type: EXPERIMENTAL
Intervention: Cyclopenthiazide 500 micrograms
Number of subjects: 24
Study 1808632 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 24
Study 6339293 — intervention group
Group type: EXPERIMENTAL
Intervention: Halometasone/triclosan cream
Number of subjects: 183
Study 6339293 — intervention group
Group type: COMPARATOR
Intervention: Nerisona C cream
Number of subjects: 183
Study 31390890 — intervention group
Group type: EXPERIMENTAL
Intervention: Peer counseling intervention to promote exclusive breastfeeding
Number of subjects: 0
Study 31390890 — intervention group
Group type: COMPARATOR
Intervention: Nonexperimental estimates
Number of subjects: 0
Study 31390890 — intervention group
Group type: EXPERIMENTAL
Intervention: Tests for nonconsent bias in the benchmark RFE
Number of subjects: 0
Study 29944044 — intervention group
Group type: EXPERIMENTAL
Intervention: Laser assisted hatching (LAH) for fresh embryos
Number of subjects: 240
Study 29944044 — intervention group
Group type: COMPARATOR
Intervention: Non laser assisted hatching (non LAH) for fresh embryos
Number of subjects: 240
Study 29944044 — intervention group
Group type: EXPERIMENTAL
Intervention: Laser assisted hatching (LAH) for frozen embryos
Number of subjects: 240
Study 29944044 — intervention group
Group type: COMPARATOR
Intervention: Non laser assisted hatching (non LAH) for frozen embryos
Number of subjects: 240
Study 26312613 — intervention group
Group type: EXPERIMENTAL
Intervention: PRONTO training program
Number of subjects: 24
Study 26312613 — intervention group
Group type: COMPARATOR
Intervention: Control (no intervention)
Number of subjects: 24
Study 24549596 — intervention group
Group type: EXPERIMENTAL
Intervention: Metformin treatment (1,000 mg/day)
Number of subjects: 178
Study 24549596 — intervention group
Group type: COMPARATOR
Intervention: Obese PCOS women
Number of subjects: 178
Study 24549596 — intervention group
Group type: COMPARATOR
Intervention: Lean PCOS women
Number of subjects: 178
Study 22131086 — intervention group
Group type: EXPERIMENTAL
Intervention: Plyometric training for 14 weeks
Number of subjects: 19
Study 22131086 — intervention group
Group type: COMPARATOR
Intervention: Control group (no plyometric training)
Number of subjects: 19
Study 21049734 — intervention group
Group type: EXPERIMENTAL
Intervention: Topical formulation containing kojic acid, emblica extract, and glycolic acid
Number of subjects: 80
Study 21049734 — intervention group
Group type: COMPARATOR
Intervention: Hydroquinone 4%
Number of subjects: 80
Study 18201437 — intervention group
Group type: EXPERIMENTAL
Intervention: Ranitidine (150 mg daily)
Number of subjects: 21
Study 18201437 — intervention group
Group type: EXPERIMENTAL
Intervention: Loratadine (10 mg daily)
Number of subjects: 21
Study 18201437 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 21
Study 16877479 — intervention group
Group type: EXPERIMENTAL
Intervention: Phototherapy with white curtains (n = 50)
Number of subjects: 97
Study 16877479 — intervention group
Group type: COMPARATOR
Intervention: Single phototherapy without curtains (n = 47)
Number of subjects: 97
Study 12037372 — intervention group
Group type: EXPERIMENTAL
Intervention: Elmex toothpaste for unsupervised home use daily and Elmex gel for use once a week
Number of subjects: 0
Study 12037372 — intervention group
Group type: EXPERIMENTAL
Intervention: Elmex toothpaste and placebo gel
Number of subjects: 0
Study 12037372 — intervention group
Group type: COMPARATOR
Intervention: Control group (usual oral care habits)
Number of subjects: 0
Study 10208146 — intervention group
Group type: EXPERIMENTAL
Intervention: Writing about the most stressful event of their lives (n = 71; 39 asthma, 32 rheumatoid arthritis)
Number of subjects: 112
Study 10208146 — intervention group
Group type: COMPARATOR
Intervention: Writing about emotionally neutral topics (n = 41; 22 asthma, 19 rheumatoid arthritis)
Number of subjects: 112
Study 10208146 — intervention group
Group type: EXPERIMENTAL
Intervention: Combined group of experimental patients (n = 70)
Number of subjects: 112
Study 10208146 — intervention group
Group type: COMPARATOR
Intervention: Combined group of control patients (n = 37)
Number of subjects: 112
Study 7897151 — intervention group
Group type: EXPERIMENTAL
Intervention: Hydroxyzine 25 mg with cimetidine 600 mg every 12 hours for 10 days
Number of subjects: 16
Study 7897151 — intervention group
Group type: EXPERIMENTAL
Intervention: Cetirizine 10 mg with cimetidine 600 mg every 12 hours for 10 days
Number of subjects: 16
Study 7897151 — intervention group
Group type: COMPARATOR
Intervention: Hydroxyzine alone
Number of subjects: 16
Study 7897151 — intervention group
Group type: COMPARATOR
Intervention: Cetirizine alone
Number of subjects: 16
Study 2650604 — intervention group
Group type: EXPERIMENTAL
Intervention: Rectal endosonography (ES)
Number of subjects: 0
Study 334222 — intervention group
Group type: EXPERIMENTAL
Intervention: Nomifensine
Number of subjects: 29
Study 334222 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 29
Study 31136331 — intervention group
Group type: EXPERIMENTAL
Intervention: ISB + Pecs II
Number of subjects: 40
Study 31136331 — intervention group
Group type: COMPARATOR
Intervention: ISB
Number of subjects: 40
Study 27984446 — intervention group
Group type: EXPERIMENTAL
Intervention: Primary wound closure
Number of subjects: 83
Study 25425638 — intervention group
Group type: EXPERIMENTAL
Intervention: Zidovudine (ZDV)
Number of subjects: 852
Study 25425638 — intervention group
Group type: COMPARATOR
Intervention: Stavudine (d4T)
Number of subjects: 852
Study 25425638 — intervention group
Group type: COMPARATOR
Intervention: Tenofovir (TDF)
Number of subjects: 852
Study 23843020 — intervention group
Group type: COMPARATOR
Intervention: Conference calls (CC)
Number of subjects: 257
Study 23843020 — intervention group
Group type: EXPERIMENTAL
Intervention: Individual calls (IC)
Number of subjects: 257
Study 22138879 — intervention group
Group type: EXPERIMENTAL
Intervention: 8-week community-based exercise program (2 times per week) with home exercise program (HEP)
Number of subjects: 19
Study 22138879 — intervention group
Group type: COMPARATOR
Intervention: Control group (no intervention specified)
Number of subjects: 19
Study 19370449 — intervention group
Group type: EXPERIMENTAL
Intervention: SPIFA
Number of subjects: 336
Study 19370449 — intervention group
Group type: COMPARATOR
Intervention: Modified SCID for Axis I disorders
Number of subjects: 336
Study 17699310 — intervention group
Group type: EXPERIMENTAL
Intervention: Omacor 4-g dosage
Number of subjects: 73
Study 17699310 — intervention group
Group type: EXPERIMENTAL
Intervention: Omacor 8-g dosage
Number of subjects: 73
Study 17699310 — intervention group
Group type: EXPERIMENTAL
Intervention: Omacor (both dosages)
Number of subjects: 73
Study 15059708 — intervention group
Group type: EXPERIMENTAL
Intervention: Photodynamic therapy (PDT) with verteporfin
Number of subjects: 14
Study 16006297 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-carbohydrate diet (N = 25)
Number of subjects: 75
Study 16006297 — intervention group
Group type: COMPARATOR
Intervention: Low-fat diet (N = 22)
Number of subjects: 75
Study 10591288 — intervention group
Group type: EXPERIMENTAL
Intervention: Collaborative care intervention (n = 114)
Number of subjects: 228
Study 10591288 — intervention group
Group type: COMPARATOR
Intervention: Usual care (n = 114)
Number of subjects: 228
Study 7534216 — intervention group
Group type: EXPERIMENTAL
Intervention: Laryngeal mask airway (LMA) insertion
Number of subjects: 46
Study 7534216 — intervention group
Group type: EXPERIMENTAL
Intervention: Tracheal intubation
Number of subjects: 46
Study 1903847 — intervention group
Group type: EXPERIMENTAL
Intervention: rhGM-CSF
Number of subjects: 128
Study 1903847 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 128
Study 6165425 — intervention group
Group type: EXPERIMENTAL
Intervention: 5-Fluorouracil
Number of subjects: 25
Study 6165425 — intervention group
Group type: EXPERIMENTAL
Intervention: BCNU
Number of subjects: 25
Study 6165425 — intervention group
Group type: COMPARATOR
Intervention: Close observation
Number of subjects: 25
Study 31085424 — intervention group
Group type: EXPERIMENTAL
Intervention: Meaningful social groups
Number of subjects: 151
Study 31085424 — intervention group
Group type: COMPARATOR
Intervention: Arbitrary social groups
Number of subjects: 151
Study 31085424 — intervention group
Group type: EXPERIMENTAL
Intervention: Stressing the arbitrariness of the grouping dimension
Number of subjects: 151
Study 28393757 — intervention group
Group type: EXPERIMENTAL
Intervention: LUCAS-2 mechanical chest compression
Number of subjects: 4471
Study 28393757 — intervention group
Group type: COMPARATOR
Intervention: Manual chest compressions (control)
Number of subjects: 4471
Study 26804646 — intervention group
Group type: EXPERIMENTAL
Intervention: JNJ‐40411813 (50mg to 150 mg b.i.d, flexibly dosed)
Number of subjects: 121
Study 26804646 — intervention group
Group type: EXPERIMENTAL
Intervention: JNJ‐40411813
Number of subjects: 121
Study 26804646 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 121
Study 24521953 — intervention group
Group type: EXPERIMENTAL
Intervention: Weight-based dosing (20 mg/kg)
Number of subjects: 20
Study 24521953 — intervention group
Group type: COMPARATOR
Intervention: Standard dosing (1 g)
Number of subjects: 20
Study 22172554 — intervention group
Group type: EXPERIMENTAL
Intervention: Choline supplementation (1 g per day as choline bitartrate)
Number of subjects: 42
Study 22172554 — intervention group
Group type: COMPARATOR
Intervention: Placebo supplement
Number of subjects: 42
Study 20167991 — intervention group
Group type: EXPERIMENTAL
Intervention: efavirenz plus didanosine plus lamivudine (group 1)
Number of subjects: 49
Study 20167991 — intervention group
Group type: EXPERIMENTAL
Intervention: didanosine plus abacavir (group 3)
Number of subjects: 49
Study 20167991 — intervention group
Group type: COMPARATOR
Intervention: tenofovir disoproxil fumarate plus lamivudine (group 2)
Number of subjects: 49
Study 20167991 — intervention group
Group type: EXPERIMENTAL
Intervention: All groups
Number of subjects: 49
Study 16963184 — intervention group
Group type: COMPARATOR
Intervention: Placebo condition
Number of subjects: 0
Study 15780099 — intervention group
Group type: EXPERIMENTAL
Intervention: Sirolimus combined with low-dose calcineurin inhibitors
Number of subjects: 16
Study 15780099 — intervention group
Group type: COMPARATOR
Intervention: Standard immunosuppression regimen (Control)
Number of subjects: 16
Study 11883835 — intervention group
Group type: EXPERIMENTAL
Intervention: Magnesium sulfate (MgSO4) therapy
Number of subjects: 40
Study 11883835 — intervention group
Group type: COMPARATOR
Intervention: Control solution
Number of subjects: 40
Study 9687101 — intervention group
Group type: EXPERIMENTAL
Intervention: Amoxycillin (5, 7.5, or 10 mg/kg)
Number of subjects: 12
Study 9687101 — intervention group
Group type: EXPERIMENTAL
Intervention: Amoxycillin (any dose)
Number of subjects: 12
Study 9687101 — intervention group
Group type: EXPERIMENTAL
Intervention: Cefpodoxime proxetil (2.5, 5, 7.5, or 10 mg/kg)
Number of subjects: 12
Study 9687101 — intervention group
Group type: EXPERIMENTAL
Intervention: Cefuroxime axetil (2.5, 5, 7.5, or 10 mg/kg)
Number of subjects: 12
Study 9687101 — intervention group
Group type: EXPERIMENTAL
Intervention: Amoxycillin (oral doses)
Number of subjects: 12
Study 9687101 — intervention group
Group type: EXPERIMENTAL
Intervention: Cefpodoxime proxetil (oral doses)
Number of subjects: 12
Study 9687101 — intervention group
Group type: EXPERIMENTAL
Intervention: Cefuroxime axetil (oral doses)
Number of subjects: 12
Study 8543963 — intervention group
Group type: EXPERIMENTAL
Intervention: Proportional hazards analysis with varying events per variable (EPV)
Number of subjects: 673
Study 8543963 — intervention group
Group type: EXPERIMENTAL
Intervention: Monte Carlo simulations
Number of subjects: 673
Study 2198932 — intervention group
Group type: EXPERIMENTAL
Intervention: Acetazolamide tablets
Number of subjects: 20
Study 2198932 — intervention group
Group type: COMPARATOR
Intervention: Sustet
Number of subjects: 20
Study 30786336 — intervention group
Group type: EXPERIMENTAL
Intervention: TTMB
Number of subjects: 142
Study 30786336 — intervention group
Group type: COMPARATOR
Intervention: TTSB
Number of subjects: 142
Study 28886739 — intervention group
Group type: EXPERIMENTAL
Intervention: PEP Intervention practices (education, clinical audit and feedback, practice facilitation)
Number of subjects: 589
Study 28886739 — intervention group
Group type: COMPARATOR
Intervention: Control group (no specific intervention mentioned)
Number of subjects: 589
Study 28886739 — intervention group
Group type: EXPERIMENTAL
Intervention: PEP Intervention practices
Number of subjects: 589
Study 28886739 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 589
Study 27185718 — intervention group
Group type: EXPERIMENTAL
Intervention: Extraglottic airway devices (EADs) with mask aperture bars (MABs)
Number of subjects: 80
Study 27185718 — intervention group
Group type: COMPARATOR
Intervention: Extraglottic airway devices (EADs) without mask aperture bars (MABs)
Number of subjects: 80
Study 24555751 — intervention group
Group type: EXPERIMENTAL
Intervention: Photodynamic therapy (PDT)
Number of subjects: 22
Study 24555751 — intervention group
Group type: COMPARATOR
Intervention: Photosensitizer (PS)
Number of subjects: 22
Study 24555751 — intervention group
Group type: COMPARATOR
Intervention: Scaling and root planing (SRP)
Number of subjects: 22
Study 22383630 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral pioglitazone (PIO) 15 mg once daily for 12 weeks
Number of subjects: 36
Study 19796343 — intervention group
Group type: EXPERIMENTAL
Intervention: Group intervention (GRP)
Number of subjects: 246
Study 19796343 — intervention group
Group type: EXPERIMENTAL
Intervention: Telephone counseling (TC)
Number of subjects: 246
Study 19796343 — intervention group
Group type: COMPARATOR
Intervention: Usual care (UC)
Number of subjects: 246
Study 17315049 — intervention group
Group type: EXPERIMENTAL
Intervention: Sitagliptin
Number of subjects: 0
Study 15030738 — intervention group
Group type: EXPERIMENTAL
Intervention: Docetaxel in combination with cisplatin (DP)
Number of subjects: 3
Study 15030738 — intervention group
Group type: COMPARATOR
Intervention: Other cisplatin-based regimens
Number of subjects: 3